Clinuvel (CUV) is held by 5 ASX ETFs. Over the last 3 months it fell 25.3%: on $10,000, −$2532. We explain 3 big moves in that time.
About CUV
- SectorHealth Care
- IndustryPharmaceuticals, Biotechnology & Life Sciences
- Size$406.4m
- Held by5 ETFs
- Big moves3 in 3M
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- +2.7%peak +3.6%1 Sep 2026· Operational
Clinuvel's announcement that it is considering a Nasdaq listing and potential ASX delisting spooked ASX investors, triggering a sell-off on elevated volume several days after the news dropped.
- −12.7%peak −18.5%27 Aug 2026· Earnings Miss
Clinuvel's FY26 full-year results disappointed the market, triggering a sharp sell-off despite a decade of profitability headline, as investors reacted negatively to the actual numbers or forward outlook in the annual report and preliminary final report released minutes before the price move.
- +5.8%peak +6.3%18 Aug 2026· Sector Flow
CUV rose sharply as the broader ASX healthcare sector surged strongly on the same day, lifting sector peers including CUV.
Held by 5 ETFs
Of every $10,000 in each fund, how much is in CUV today.
Why did CUV rise 2.7% on 1 Sep 2026?
Clinuvel
Clinuvel's announcement that it is considering a Nasdaq listing and potential ASX delisting spooked ASX investors, triggering a sell-off on elevated volume several days after the news dropped.
The most material company-specific news from the prior 7 days was the 27 August announcement that Clinuvel is considering a Nasdaq listing and ASX delisting — a significant structural change that would remove ASX liquidity and create uncertainty for existing ASX shareholders, naturally prompting selling. The sector signal (AXHJ -0.6%) is well below threshold and explains only a trivial fraction of the -5.31% move, ruling out sector rotation as the primary driver. No direct earnings miss or guidance cut is evident; the FY26 report and decade-of-profitability narrative were broadly positive, suggesting the delisting/listing-migration announcement is the dominant catalyst for the delayed but amplified sell-off on 1 September.
Written by a language model from the evidence below, and it can be wrong. Tell us and we will fix or remove it. General information only, not financial product advice. It does not consider your objectives, finances or needs. Past performance is not a guide to future performance.
Evidence
News coverage
Sector / macro signals
What it did to the 5 ETFs holding CUV
On $10,000 in each fund, at the weight it holds today